SOURCE: The study was led by Kit Curtius, Bioinformatics and Systems Biology, University of California, San Diego, and was presented at Digestive Disease Week (DDW) 2026 in Chicago
People with active or suspected cancer: Despite GHK-Cus anti-cancer potential, it theoretically could promote the formation of new blood vessels, which can feed tumors.3 9 14 People with anxiety or mood disorders: Similarly, although GHK-Cu has demonstrated an anxiolytic and anti-aggression effect in rats, the present research is too meager to support it as a viable treatment for anxiety or mood disorders
TB-500, BPC-157, KPV, and GHK-Cu are research peptides and are not FDA-approved for human use
The peptide has been extensively researched for its role in weight management
BPC-157 contributes particularly robust wound healing acceleration through its comprehensive effects on cellular migration, proliferation, and angiogenesis
2 an average image of all three coverslips was shown